Detalhe da pesquisa
1.
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
Nat Immunol
; 25(4): 633-643, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38486021
2.
ß-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
Cell
; 183(6): 1520-1535.e14, 2020 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33157038
3.
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
Cell
; 182(3): 744-753.e4, 2020 08 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32553273
4.
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
Cell
; 182(3): 734-743.e5, 2020 08 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32643603
5.
Lessons for COVID-19 Immunity from Other Coronavirus Infections.
Immunity
; 53(2): 248-263, 2020 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32717182
6.
SARS-CoV-2 takes its Toll.
Nat Immunol
; 22(7): 801-802, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34103714
7.
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
Nature
; 605(7908): 146-151, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35314834
8.
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice.
Nature
; 589(7843): 603-607, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33166988
9.
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike.
Proc Natl Acad Sci U S A
; 121(15): e2317222121, 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38557175
10.
What's what in a pandemic? Virus, disease, and societal disaster must be differentiated.
PLoS Biol
; 21(5): e3002130, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37228002
11.
Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence.
Proc Natl Acad Sci U S A
; 120(31): e2305674120, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37487098
12.
Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection.
J Virol
; 98(1): e0151023, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38168680
13.
Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.
Immunity
; 44(6): 1379-91, 2016 06 21.
Artigo
Inglês
| MEDLINE | ID: mdl-27287409
14.
Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses.
Proc Natl Acad Sci U S A
; 119(42): e2202871119, 2022 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36215506
15.
MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells.
Proc Natl Acad Sci U S A
; 119(21): e2123208119, 2022 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35594398
16.
Monovalent SARS-CoV-2 mRNA Vaccine Does not Boost Omicron-Specific Immune Response in Diabetic and Control Pediatric Patients.
J Infect Dis
; 229(4): 1059-1067, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37624979
17.
COVID-19: Inflammatory Profile.
Annu Rev Med
; 73: 65-80, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34437814
18.
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
J Virol
; 97(11): e0144823, 2023 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37855638
19.
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice.
PLoS Pathog
; 18(9): e1010782, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36121829
20.
Advances and gaps in SARS-CoV-2 infection models.
PLoS Pathog
; 18(1): e1010161, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35025969